Skip to main content
. 2020 Mar 25;111(5):1685–1691. doi: 10.1111/cas.14368

TABLE 1.

Patient characteristics

Characteristics No. of patients (%)
Gender
Male 8997 (73.0)
Female 3323 (27.0)
Age
Median (range) 70 (22‐102)
Mean (standard deviation) 69.3 (±10.2)
Smoking status
Never smoker 2489 (20.2)
Former smoker 4808 (39.0)
Current smoker 5023 (40.8)
TNM stage
T‐factor
TX 353 (2.9)
T0 31 (0.3)
Tis 16 (0.3)
T1a 856 (6.9)
T1b 1246 (10.1)
T2a 2678 (21.7)
T2b 1084 (8.8)
T3 2243 (18.2)
T4 3813 (30.9)
N‐factor
NX 165 (1.3)
N0 2056 (16.7)
N1 1274 (10.3)
N2 4058 (32.9)
N3 4767 (38.7)
M‐factor
M0 4155 (33.7)
M1a 2450 (19.9)
M1b 5715 (46.4)
Stage
IA 261 (2.1)
IB 207 (1.7)
IIA 253 (2.1)
IIB 168 (1.4)
IIIA 1535 (12.5)
IIIB 1725 (14.0)
IV 8171 (66.3)
Histology
Non–small cell lung cancer 9872 (80.1)
Adenocarcinoma 6276 (50.9)
Squamous cell carcinoma 2602 (21.1)
Large cell 165 (1.3)
Adenosquamous 60 (0.5)
Not otherwise specified 632 (5.1)
Others 137 (1.1)
Small cell lung cancer 2353 (19.1)
Others 19 (0.2)
Unknown 76 (0.6)
Performance status
0 3783 (30.7)
1 5701 (46.3)
2 1515 (12.3)
3 921 (7.5)
4 400 (3.2)